SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-16-005930
Filing Date
2016-05-12
Accepted
2016-05-12 16:37:04
Documents
2
Period of Report
2016-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mirn-20160512x8k.htm 8-K 26908
2 EX-99.1 mirn-20160512ex991df1602.htm EX-99.1 140397
  Complete submission text file 0001558370-16-005930.txt   168409
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 161644485
SIC: 2834 Pharmaceutical Preparations